Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun 1;99(11):2691-700.
doi: 10.1172/JCI119458.

Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor

Affiliations

Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor

R J Blair et al. J Clin Invest. .

Abstract

The presence of mast cells near capillary sprouting sites suggests an association between mast cells and angiogenesis. However, the role of mast cells in blood vessel development remains to be defined. In an attempt to elucidate this relationship, we investigated the effect of human mast cells (HMC-1) and their products on human dermal microvascular endothelial cell (HDMEC) tube formation. Coculture of HMC-1 with HDMEC led to a dose-response increase in the network area of vascular tube growth. Moreover, the extent of neovascularization was enhanced greatly when HMC-1 were degranulated in the presence of HDMEC. Further examination using antagonists to various mast cell products revealed a blunted response (73-88% decrease) in the area of vascular tube formation if specific inhibitors of tryptase were present. Tryptase (3 microg/ml) directly added to HDMEC caused a significant augmentation of capillary growth, which was suppressed by specific tryptase inhibitors. Tryptase also directly induced cell proliferation of HDMEC in a dose-dependent fashion (2 pM-2 nM). Our results suggest that mast cells act at sites of new vessel formation by secreting tryptase, which then functions as a potent and previously unrecognized angiogenic factor.

PubMed Disclaimer

References

    1. Br J Dermatol. 1970 Feb;82(2):99-117 - PubMed
    1. Cancer. 1963 Apr;16:453-67 - PubMed
    1. Br J Dermatol. 1979 Jun;100(6):635-40 - PubMed
    1. J Exp Med. 1980 Oct 1;152(4):931-44 - PubMed
    1. Nature. 1980 Dec 11;288(5791):551-6 - PubMed

Publication types

MeSH terms